EYP-1901 for Retinal Exudative Diseases - Top_Thought_Leaders - MDSpire

EYP-1901 for Retinal Exudative Diseases

An overview of the current status of the EYP-1901 clinical trial program in wet AMD and DME, presented at Hawaiian Eye and Retina 2026

  • By

  • Sumit Sharma

  • January 23, 2026

  • 5 min

Share

Top Thought Leaders in Neurology

Brief introduction explaining scope and methodology.

Original Source(s)

EYP-1901 for Retinal Exudative Diseases

  • by Sumit Sharma

  • January 23, 2026

Related Content

Direct Amoxicillin Challenges for Penicillin Allergy Through Pediatric Primary Care Group Visits: A Pilot Study

In memory of Kristin Page 1974–2024

Hospital-Treated Infections Linked to Dementia Risk

Investigators identify 29 conditions associated with dementia risk in nationwide registry analysis.